Screener
Mirum Pharmaceuticals, Inc. MIRM Gross Carrying Amount
Gross Carrying Amount at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | Gross Carrying Value | Accumulated Amortization | Net Carrying Amount | Weighted-Average Remaining Amortization Period (Years) |
|---|---|---|---|---|
| Commercial milestones | $94,000 | $(15,527) | $78,473 | 11.1 |
| Developed technology | 226,620 | (57,759) | 168,861 | 9.3 |
| Assembled workforce | 970 | (916) | 54 | 0.2 |
| Total intangible assets | $321,590 | $(74,202) | $247,388 | 9.8 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s gross carrying amount?
- Mirum Pharmaceuticals, Inc. (MIRM) reported gross carrying amount of $321.59M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s gross carrying amount changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s gross carrying amount increased by 12.2% year-over-year, from $286.59M to $321.59M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s gross carrying amount?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s gross carrying amount has grown at a 9.8% compound annual growth rate (CAGR), from $266.59M to $321.59M.
- What does gross carrying amount mean?
- Gross Carrying Amount
Ask your AI about Mirum Pharmaceuticals, Inc.'s gross carrying amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude